The efficacy of vitamin D supplementation in dry eye disease: A systematic review and meta-analysis
Zeying Chen,Chengxiao Zhang,Jiaxuan Jiang,Junwen Ouyang,Di Zhang,Taige Chen,Yiran Chu,Kai Hu
DOI: https://doi.org/10.1016/j.clae.2024.102169
IF: 3.946
2024-07-19
Contact Lens and Anterior Eye
Abstract:Purpose Vitamin D (VD) is a vitamin with anti-inflammatory and immunomodulatory effects. Several studies have shown that VD deficiency is associated with the incidence and severity of dry eye disease (DED) in humans. This meta -analysis compared signs and symptoms in patients with DED before and after VD supplementation. Methods Ten databases (PubMed, Cochrane, Web of science, Ovid, Embase, Scopus, CNKI, CSTJ, Wanfang, Sinomed) and four clinical trials registry websites (ISRCTN, CT, ICTRP, ICH GCP) were searched for studies on the efficacy of VD supplement in patients with DED that were published up to 2023 January. A total of 8 studies with 439 cases were included. Two reviewers independently assessed the quality of the literature and extracted data to calculate standard mean differences (SMD) for the Schirmer's test (SH test), tear film break-up time (TBUT), corneal fluorescein staining scores (CFSS, Oxford Scale, 0–5), lid hyperemia, ocular surface disease index (OSDI), and visual analogue pain scale (VAS). Results The analysis showed that VD supplementation improved tear production (SMD 1.43, 95% CI 0.81, 2.05, p = 0.000) and tear film stability (SMD 1.19, 95% CI 0.83, 1.55, p = 0.000) and reduced lid hyperemia (SMD −0.71, 95% CI −1.09, −0.32, p = 0.000) and OSDI (SMD −1.10, 95% CI −1.45, −0.74, p = 0.000), which is effective in alleviating the signs and symptoms of DED. Conclusions VD supplementation could be an adjuvant treatment to alleviate the signs and symptoms of dry eye in the future. However, further studies regarding its most appropriate administration and dosage need to be conducted.
ophthalmology